Nifty

:

23346.40

Sensex

:

74294.96

75.80 (0.33%)
-19.63 (-0.03%)

Login

Nifty
Sensex

:
:

23346.40
74294.96

75.80 (0.33%)
-19.63 (-0.03%)

Marksans Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :

73/99

BSE: 524404 | NSE: MARKSANS

Watchlist

NSE BSE

320.15

18-Sep-2026

Open
High
Low
Previous Close

321.35
325.85
318.65
319.70

Volume
Traded Value (lacs)
52 Week High
52 Week Low

975318
313174317.5
349.95
155

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

14,492.18
28.05
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

13,532.12
0.28%
4.56

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.42
14.63
10.66

EBITDA CAGR (%)

10 Years
5 Years
3 Years

33.70
18.34
5.55

PAT CAGR (%)

10 Years
5 Years
3 Years

47.07
17.76
10.03

P:E (Median)

8 Years
5 Years
3 Years

15.57
22.06
24.98

P:BV (Average)

8 Years
5 Years
3 Years

2.88
3.24
4.01

EV:EBITDA (Average)

8 Years
5 Years
3 Years

10.67
12.20
15.56

Earnings Forecasts:

(Updated: 19-09-2026)

Description 2026 2027 2028 2029
Adj EPS 48 18 24.66 8.61
P/E Ratio 6.67 17.79 12.98 37.18
Revenue 23.63 19.97 15.75 2897.15
EBITDA 3435.48 3938.08 4580 566.1
Net Income 715.9 838.93 1030.5 390.88
ROA 512.55 607.4 768.9 11
P/B Ratio -0.28 -0.23 - 5.18
ROE 3.44 3.13 2.49 14.38
FCFF 16.03 16.36 - 327.7
FCFF Yield 334.55 426.95 - 2.85
Net Debt 2.91 3.72 - -916.75
BVPS -1135.5 -1414 - 61.76

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 321.19 319.73 0.46% 361.57 299.36 20.78% 339.73 311.87 8.93% 320.44 308.63 3.83%
Expenses 239.08 249.68 -4.25% 255.58 247.60 3.22% 264.28 260.19 1.57% 248.37 245.22 1.28%
EBITDA 82.10 70.05 17.20% 105.99 51.76 104.77% 75.44 51.68 45.98% 72.07 63.40 13.68%
EBIDTM 25.56% 21.91% 29.31% 17.29% 22.21% 16.57% 22.49% 20.54%
Other Income 17.47 2.01 769.15% 27.48 6.64 313.86% 15.86 30.77 -48.46% 58.19 20.23 187.64%
Interest 0.34 0.30 13.33% 0.35 0.31 12.90% 0.36 0.30 20.00% 0.32 0.28 14.29%
Depreciation 8.78 8.19 7.20% 8.76 8.18 7.09% 8.83 7.42 19.00% 8.46 7.02 20.51%
PBT 90.46 63.57 42.30% 124.36 49.90 149.22% 82.12 74.72 9.90% 121.49 76.34 59.14%
Tax 21.42 15.52 38.02% 32.44 12.31 163.53% 21.20 19.26 10.07% 21.69 13.13 65.19%
PAT 69.04 48.06 43.65% 91.92 37.59 144.53% 60.91 55.46 9.83% 99.81 63.20 57.93%
PATM 21.49% 15.03% 25.42% 12.56% 17.93% 17.78% 31.15% 20.48%
EPS 1.52 1.06 43.40% 2.03 0.83 144.58% 1.34 1.22 9.84% 2.20 1.39 58.27%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 840.80 619.99 35.62% 856.11 708.46 20.84% 754.43 681.85 10.64% 720.41 641.92 12.23%
Expenses 627.76 519.87 20.75% 660.69 581.52 13.61% 593.69 551.35 7.68% 575.92 495.11 16.32%
EBITDA 213.03 100.12 112.77% 195.42 126.93 53.96% 160.74 130.50 23.17% 144.49 146.81 -1.58%
EBIDTM 25.34% 16.15% 22.83% 17.92% 21.31% 19.14% 20.06% 22.87%
Other Income 25.40 5.64 350.35% 35.17 15.34 129.27% 20.14 36.11 -44.23% 21.57 -0.07 -
Interest 7.00 6.06 15.51% 6.31 3.44 83.43% 5.94 2.67 122.47% 5.81 2.63 120.91%
Depreciation 24.86 23.10 7.62% 24.29 22.74 6.82% 24.33 20.69 17.59% 26.92 19.51 37.98%
PBT 206.57 76.60 169.67% 200.00 116.09 72.28% 150.62 143.26 5.14% 133.33 124.60 7.01%
Tax 47.16 18.40 156.30% 50.97 25.37 100.91% 36.93 38.19 -3.30% 34.20 26.84 27.42%
PAT 159.41 58.20 173.90% 149.03 90.73 64.26% 113.69 105.07 8.20% 99.14 97.76 1.41%
PATM 18.96% 9.39% 17.41% 12.81% 15.07% 15.41% 13.76% 15.23%
EPS 3.47 1.29 168.99% 3.27 2.00 63.50% 2.50 2.31 8.23% 2.17 2.13 1.88%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 1,342.93 1,341.48 1,174.37 853.27 655.20 658.29 599.55 433.42 424.16 294.66 215.84 Net Sales Growth 8.34% 14.23% 37.63% 30.23% -0.47% 9.80% 38.33% 2.18% 43.95% 36.52% Cost Of Goods Sold 671.85 678.79 639.94 478.93 394.44 377.59 337.91 245.41 236.34 169.35 112.37 Gross Profit 671.08 662.69 534.44 374.34 260.75 280.70 261.63 188.00 187.82 125.31 103.47 GP Margin 49.97% 49.40% 45.51% 43.87% 39.80% 42.64% 43.64% 43.38% 44.28% 42.53% 47.94% Total Expenditure 1,007.31 1,017.91 966.28 713.34 582.23 544.57 485.84 361.93 360.83 265.52 202.15 Power & Fuel Cost - 32.95 30.73 26.04 14.24 11.49 10.90 8.95 8.44 7.26 7.21 % Of Sales - 2.46% 2.62% 3.05% 2.17% 1.75% 1.82% 2.06% 1.99% 2.46% 3.34% Employee Cost - 121.98 101.68 77.19 56.09 60.46 54.64 48.51 46.33 45.86 39.77 % Of Sales - 9.09% 8.66% 9.05% 8.56% 9.18% 9.11% 11.19% 10.92% 15.56% 18.43% Manufacturing Exp. - 65.94 64.62 46.09 26.22 5.25 12.29 8.68 12.69 11.52 11.99 % Of Sales - 4.92% 5.50% 5.40% 4.00% 0.80% 2.05% 2.00% 2.99% 3.91% 5.56% General & Admin Exp. - 31.63 36.24 27.40 21.36 16.58 14.79 16.19 22.68 10.95 10.61 % Of Sales - 2.36% 3.09% 3.21% 3.26% 2.52% 2.47% 3.74% 5.35% 3.72% 4.92% Selling & Distn. Exp. - 65.08 76.75 45.79 53.97 59.37 52.67 33.84 34.30 20.58 20.20 % Of Sales - 4.85% 6.54% 5.37% 8.24% 9.02% 8.78% 7.81% 8.09% 6.98% 9.36% Miscellaneous Exp. - 21.55 16.32 11.88 15.89 13.84 2.64 0.34 0.04 0.00 20.20 % Of Sales - 1.61% 1.39% 1.39% 2.43% 2.10% 0.44% 0.08% 0.01% 0% 0% EBITDA 335.60 323.57 208.09 139.93 72.97 113.72 113.71 71.49 63.33 29.14 13.69 EBITDA Margin 24.99% 24.12% 17.72% 16.40% 11.14% 17.28% 18.97% 16.49% 14.93% 9.89% 6.34% Other Income 119.00 103.53 65.79 62.07 79.41 42.25 31.16 0.17 7.93 7.43 17.75 Interest 1.37 1.33 1.17 0.99 3.61 3.80 5.34 7.29 6.56 7.67 4.49 Depreciation 34.83 34.23 29.45 29.13 16.74 17.66 15.19 11.64 8.69 12.25 15.00 PBT 418.43 391.54 243.26 171.89 132.03 134.51 124.33 52.73 56.01 16.65 11.95 Tax 96.75 90.84 54.99 38.13 29.17 30.52 25.95 14.82 12.39 4.23 0.40 Tax Rate 23.12% 23.20% 22.61% 22.18% 22.09% 22.69% 20.87% 28.11% 22.12% 25.41% 3.35% PAT 321.68 300.70 188.27 133.76 102.87 103.99 98.38 37.90 43.62 12.43 11.55 PAT before Minority Interest 321.68 300.70 188.27 133.76 102.87 103.99 98.38 37.90 43.62 12.43 11.55 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 23.95% 22.42% 16.03% 15.68% 15.70% 15.80% 16.41% 8.74% 10.28% 4.22% 5.35% PAT Growth 57.45% 59.72% 40.75% 30.03% -1.08% 5.70% 159.58% -13.11% 250.93% 7.62% EPS 7.10 6.64 4.15 2.95 2.27 2.29 2.17 0.84 0.96 0.27 0.25

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 3,171.75 2,950.94 2,622.84 2,177.41 1,852.14 1,490.84 1,376.18 1,134.21 1,000.07 912.69 767.16 Net Sales Growth 19.59% 12.51% 20.46% 17.56% 24.23% 8.33% 21.33% 13.41% 9.57% 18.97% Cost Of Goods Sold 1,358.94 1,277.28 1,143.74 1,038.12 921.36 716.81 595.05 567.83 498.01 523.13 458.74 Gross Profit 1,812.81 1,673.66 1,479.10 1,139.29 930.78 774.02 781.13 566.38 502.07 389.57 308.42 GP Margin 57.15% 56.72% 56.39% 52.32% 50.25% 51.92% 56.76% 49.94% 50.20% 42.68% 40.20% Total Expenditure 2,458.06 2,350.16 2,090.16 1,718.83 1,512.82 1,231.96 1,036.58 941.96 867.93 834.31 734.24 Power & Fuel Cost - 54.08 40.08 36.94 24.50 18.59 16.42 14.38 14.34 11.83 13.27 % Of Sales - 1.83% 1.53% 1.70% 1.32% 1.25% 1.19% 1.27% 1.43% 1.30% 1.73% Employee Cost - 420.93 350.30 293.64 239.37 220.30 197.32 168.42 159.07 147.75 149.70 % Of Sales - 14.26% 13.36% 13.49% 12.92% 14.78% 14.34% 14.85% 15.91% 16.19% 19.51% Manufacturing Exp. - 155.88 140.08 94.76 96.47 12.73 49.76 64.44 77.14 59.90 47.34 % Of Sales - 5.28% 5.34% 4.35% 5.21% 0.85% 3.62% 5.68% 7.71% 6.56% 6.17% General & Admin Exp. - 109.99 117.60 93.90 52.79 37.74 50.67 45.52 51.03 42.51 37.52 % Of Sales - 3.73% 4.48% 4.31% 2.85% 2.53% 3.68% 4.01% 5.10% 4.66% 4.89% Selling & Distn. Exp. - 260.26 256.64 127.31 133.19 119.05 111.25 81.03 68.36 49.14 27.66 % Of Sales - 8.82% 9.78% 5.85% 7.19% 7.99% 8.08% 7.14% 6.84% 5.38% 3.61% Miscellaneous Exp. - 71.74 41.72 34.16 45.14 106.73 16.10 0.34 0.00 0.05 27.66 % Of Sales - 2.43% 1.59% 1.57% 2.44% 7.16% 1.17% 0.03% 0% 0.01% 0% EBITDA 713.68 600.78 532.68 458.58 339.32 258.88 339.60 192.25 132.14 78.38 32.92 EBITDA Margin 22.50% 20.36% 20.31% 21.06% 18.32% 17.36% 24.68% 16.95% 13.21% 8.59% 4.29% Other Income 102.28 82.53 66.33 50.42 59.31 41.85 6.69 0.33 4.63 8.47 18.86 Interest 25.06 24.13 11.66 11.20 9.13 8.45 7.99 8.75 9.66 10.22 6.79 Depreciation 100.40 98.63 83.39 74.27 51.85 44.78 36.15 26.66 22.80 26.84 30.09 PBT 690.52 560.55 503.97 423.53 337.65 247.51 302.16 157.17 104.31 49.80 14.90 Tax 169.26 140.49 121.35 108.63 72.33 60.70 63.63 36.42 23.87 14.00 3.56 Tax Rate 24.51% 25.06% 24.08% 25.65% 21.42% 24.52% 21.06% 23.17% 22.88% 28.11% 23.89% PAT 521.27 417.90 380.58 313.69 266.31 184.56 235.94 117.02 76.46 32.94 8.83 PAT before Minority Interest 516.75 420.06 382.62 314.89 265.32 186.81 238.54 120.75 80.44 35.80 11.33 Minority Interest -4.52 -2.16 -2.04 -1.20 0.99 -2.25 -2.60 -3.73 -3.98 -2.86 -2.50 PAT Margin 16.43% 14.16% 14.51% 14.41% 14.38% 12.38% 17.14% 10.32% 7.65% 3.61% 1.15% PAT Growth 48.19% 9.81% 21.32% 17.79% 44.29% -21.78% 101.62% 53.05% 132.12% 273.05% EPS 11.50 9.22 8.40 6.92 5.88 4.07 5.21 2.58 1.69 0.73 0.19

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 1,652.31 1,383.49 1,222.70 1,111.32 784.67 599.72 505.63 470.57 428.97 418.88 Share Capital 45.32 45.32 45.32 45.32 40.93 40.93 40.93 40.93 40.93 40.93 Total Reserves 1,603.66 1,338.17 1,177.39 1,066.01 650.64 558.79 464.69 429.64 388.04 377.95 Non-Current Liabilities 31.47 26.18 20.89 17.00 14.41 23.93 24.79 18.39 17.09 17.30 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 5.69 5.77 4.47 3.18 1.86 2.11 1.47 1.36 1.08 0.96 Current Liabilities 371.86 386.49 304.73 240.91 190.39 137.26 79.73 135.92 113.53 109.59 Trade Payables 180.81 203.53 159.72 111.58 74.45 64.16 56.65 37.23 33.68 20.60 Other Current Liabilities 105.61 130.13 105.84 97.65 78.95 42.70 10.92 7.34 8.79 0.71 Short Term Borrowings 0.00 0.00 0.00 0.00 5.00 0.00 0.00 77.33 66.31 73.23 Short Term Provisions 85.44 52.83 39.16 31.68 31.99 30.40 12.15 14.03 4.75 15.04 Total Liabilities 2,055.64 1,796.16 1,548.32 1,369.23 989.47 760.91 610.15 624.88 559.59 545.77 Net Block 397.96 383.37 271.57 143.94 135.51 129.09 115.18 102.61 87.89 93.92 Gross Block 603.11 555.16 414.10 318.89 301.34 277.25 248.77 224.90 201.83 195.61 Accumulated Depreciation 205.15 171.79 142.52 174.95 165.83 148.16 133.59 122.28 113.94 101.69 Non Current Assets 684.95 673.08 568.33 431.10 375.75 369.32 355.73 339.98 324.78 329.16 Capital Work in Progress 0.00 0.00 0.00 3.90 0.00 0.00 0.00 0.00 0.00 0.36 Non Current Investment 267.21 265.75 265.75 265.75 236.07 236.07 236.07 236.07 236.07 234.29 Long Term Loans & Adv. 19.77 23.79 30.84 17.50 4.16 4.16 4.47 1.29 0.82 0.59 Other Non Current Assets 0.01 0.17 0.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,370.68 1,123.08 979.99 938.13 613.73 391.60 254.41 284.90 234.81 216.61 Current Investments 0.00 0.74 26.99 0.54 0.44 0.26 0.00 0.00 0.00 0.00 Inventories 189.13 205.21 190.85 130.95 103.67 93.69 74.60 70.36 42.29 29.24 Sundry Debtors 623.46 549.58 370.17 305.49 246.78 168.93 161.87 177.83 168.87 154.80 Cash & Bank 446.76 268.69 312.23 440.26 224.05 105.61 3.35 1.80 0.71 2.56 Other Current Assets 111.33 8.96 11.74 7.17 38.79 23.11 14.58 34.90 22.93 30.01 Short Term Loans & Adv. 99.80 89.89 68.00 53.71 26.73 21.20 13.76 27.43 16.85 29.92 Net Current Assets 998.83 736.59 675.27 697.22 423.34 254.34 174.68 148.98 121.28 107.02 Total Assets 2,055.63 1,796.16 1,548.32 1,369.23 989.48 760.92 610.14 624.88 559.59 545.77

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 3,023.16 2,466.91 2,065.05 1,745.16 1,202.27 886.50 636.01 542.48 470.86 433.43 Share Capital 45.32 45.32 45.32 45.32 40.93 40.93 40.93 40.93 40.93 40.93 Total Reserves 2,974.50 2,421.60 2,019.74 1,699.85 1,068.24 845.56 595.08 501.55 429.93 392.50 Non-Current Liabilities 268.17 272.91 205.20 84.33 57.05 23.70 24.15 17.14 15.64 16.07 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 5.92 5.92 4.56 3.25 1.86 2.11 1.47 1.36 1.08 0.96 Current Liabilities 527.09 477.34 389.85 340.99 380.08 298.97 228.75 232.62 234.68 296.06 Trade Payables 336.91 305.70 268.28 230.60 200.08 168.66 110.33 106.07 77.83 161.78 Other Current Liabilities 118.69 117.17 70.62 42.20 96.80 79.69 58.86 20.90 10.08 0.71 Short Term Borrowings 29.59 23.09 29.09 41.59 41.29 18.74 18.84 99.91 117.41 109.71 Short Term Provisions 41.90 31.39 21.86 26.60 41.92 31.88 40.72 5.74 29.36 23.85 Total Liabilities 3,847.94 3,239.63 2,680.95 2,190.39 1,660.10 1,228.03 902.02 802.46 730.73 751.81 Net Block 1,044.11 981.96 775.94 486.31 428.31 309.36 302.72 269.73 279.38 266.98 Gross Block 1,605.35 1,413.02 1,134.80 828.26 726.26 551.92 565.39 506.26 495.35 456.49 Accumulated Depreciation 561.24 431.06 358.87 341.95 297.96 242.56 262.67 236.54 215.97 189.52 Non Current Assets 1,125.20 1,035.51 818.46 515.09 435.04 325.20 308.45 271.02 280.19 267.92 Capital Work in Progress 58.58 27.11 9.42 9.87 2.57 11.68 0.00 0.00 0.00 0.36 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 22.50 26.27 32.94 18.91 4.16 4.16 5.73 1.29 0.82 0.59 Other Non Current Assets 0.01 0.17 0.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 2,722.74 2,204.12 1,862.49 1,675.30 1,225.07 902.82 593.59 531.44 450.54 483.88 Current Investments 0.00 0.74 26.99 0.54 0.44 0.26 0.00 0.00 0.00 0.00 Inventories 972.28 845.52 617.94 484.74 424.44 404.32 241.84 293.25 218.12 190.09 Sundry Debtors 644.57 540.04 453.18 416.85 394.78 271.95 243.35 176.60 176.91 247.58 Cash & Bank 989.65 704.21 673.58 714.96 349.26 212.18 93.73 33.54 39.88 25.16 Other Current Assets 116.25 32.41 30.98 22.74 56.15 14.11 14.66 28.06 15.63 21.05 Short Term Loans & Adv. 76.05 81.20 59.82 35.48 31.79 0.98 3.40 0.00 0.00 20.96 Net Current Assets 2,195.65 1,726.78 1,472.64 1,334.31 844.98 603.85 364.83 298.82 215.86 187.82 Total Assets 3,847.94 3,239.63 2,680.95 2,190.39 1,660.11 1,228.02 902.04 802.46 730.73 751.80

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 211.09 31.02 34.05 51.73 55.97 106.92 107.58 19.81 15.63 -13.62 PBT 391.54 243.26 171.89 132.03 134.51 124.33 52.73 56.01 16.65 11.95 Adjustment -24.66 -7.59 -16.40 10.91 -7.93 -8.82 19.17 11.57 20.00 12.50 Changes in Working Capital -82.79 -158.11 -82.68 -59.60 -38.77 11.62 46.17 -34.91 -16.33 -22.39 Cash after chg. in Working capital 284.09 77.56 72.82 83.34 87.80 127.13 118.06 32.67 20.32 2.06 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -73.01 -46.54 -38.76 -31.62 -31.83 -20.21 -10.49 -12.86 -4.68 -15.69 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -140.29 17.24 -114.22 -194.62 -128.06 8.87 -24.15 -20.20 -7.55 -7.69 Net Fixed Assets -47.95 -141.06 -91.31 -21.45 -24.09 -28.48 -23.87 -23.07 -5.86 -11.49 Net Investments -0.72 26.25 -26.45 -29.78 -0.18 -0.26 0.00 0.00 -1.78 -2.85 Others -91.62 132.05 3.54 -143.39 -103.79 37.61 -0.28 2.87 0.09 6.65 Cash from Financing Activity -39.23 -29.92 -26.21 210.02 70.86 -13.53 -81.87 0.96 -9.98 20.74 Net Cash Inflow / Outflow 31.56 18.34 -106.38 67.12 -1.23 102.26 1.55 0.56 -1.90 -0.57 Opening Cash & Equivalents 60.27 41.93 148.31 81.19 82.42 3.35 1.80 0.55 2.45 3.13 Closing Cash & Equivalent 91.25 60.27 41.93 148.31 81.19 105.61 3.35 1.12 0.55 2.56

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 458.13 206.66 230.41 237.41 99.26 178.59 233.33 27.40 50.09 14.06 PBT 560.55 503.97 423.53 337.65 247.51 302.16 157.17 104.31 49.80 14.90 Adjustment 99.68 69.37 55.42 74.24 35.31 56.57 42.04 31.88 43.99 26.58 Changes in Working Capital -62.46 -240.77 -126.19 -111.47 -110.70 -131.61 59.12 -81.79 -36.23 -6.04 Cash after chg. in Working capital 597.78 332.56 352.76 300.43 172.12 227.12 258.33 54.40 57.56 35.44 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -139.65 -125.90 -122.35 -63.01 -72.86 -48.53 -25.00 -27.00 -7.46 -21.37 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -248.27 -49.01 -140.84 -259.21 -84.39 -44.85 -59.58 -13.48 -38.81 -20.73 Net Fixed Assets -47.95 -141.06 -91.31 -21.45 -24.09 -28.48 -23.87 -23.07 -5.86 -11.49 Net Investments -0.72 26.25 -26.45 -29.78 -0.18 -0.26 0.00 0.00 -1.78 -2.85 Others -199.60 65.80 -23.08 -207.98 -60.12 -16.11 -35.71 9.59 -31.17 -6.39 Cash from Financing Activity -70.93 -65.15 -68.73 197.83 79.51 -15.29 -113.55 -20.78 3.38 -3.47 Net Cash Inflow / Outflow 138.93 92.51 20.84 176.03 94.38 118.46 60.19 -6.86 14.67 -10.14 Opening Cash & Equivalents 495.79 403.28 382.44 206.41 112.03 93.73 33.54 39.72 25.05 35.30 Closing Cash & Equivalent 634.14 495.79 403.28 382.44 206.41 212.18 93.73 32.85 39.72 25.16

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 36.39 30.53 26.98 24.52 16.90 14.65 12.35 11.50 10.48 10.23 ROA 15.61% 11.26% 9.17% 8.72% 11.88% 14.35% 6.15% 7.40% 2.25% 2.14% ROE 19.83% 14.45% 11.46% 11.41% 16.11% 17.80% 7.77% 9.70% 2.93% 2.79% ROCE 25.88% 18.76% 14.81% 14.27% 19.91% 23.46% 11.39% 11.99% 4.92% 3.44% Fixed Asset Turnover 2.38 2.43 2.33 2.24 2.30 2.30 1.83 1.99 1.48 1.14 Receivable days 155.47 142.42 144.13 144.90 114.03 99.91 143.04 149.17 200.47 243.69 Inventory Days 52.26 61.33 68.65 61.56 54.14 50.83 61.04 48.47 44.31 61.71 Payable days 103.34 103.59 103.38 86.07 66.99 65.25 47.33 37.28 36.94 45.72 Cash Conversion Cycle 104.40 100.16 109.41 120.38 101.18 85.49 156.75 160.37 207.84 259.68 Total Debt/Equity 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.17 0.16 0.17 Interest Cover 296.06 208.21 174.98 37.54 36.44 24.26 8.23 9.54 3.17 3.66

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 66.64 54.44 45.57 38.51 27.10 21.66 15.54 13.25 11.50 10.59 ROA 11.85% 12.93% 12.93% 13.78% 12.94% 22.40% 14.17% 10.49% 4.83% 1.54% ROE 15.31% 16.89% 16.53% 18.59% 18.72% 31.33% 20.49% 15.88% 7.92% 2.59% ROCE 21.10% 22.50% 22.40% 22.89% 23.82% 39.76% 25.57% 18.51% 10.60% 3.99% Fixed Asset Turnover 2.01 2.16 2.33 2.62 2.42 2.49 2.12 2.00 1.92 1.73 Receivable days 71.16 65.99 69.35 72.63 78.56 67.57 67.57 64.51 84.88 110.59 Inventory Days 109.20 97.24 87.89 81.36 97.65 84.73 86.10 93.32 81.63 85.14 Payable days 91.82 91.59 87.70 85.31 93.88 85.57 45.09 38.48 55.10 65.56 Cash Conversion Cycle 88.55 71.65 69.54 68.67 82.33 66.73 108.58 119.35 111.40 130.17 Total Debt/Equity 0.01 0.01 0.01 0.02 0.04 0.02 0.03 0.18 0.25 0.25 Interest Cover 24.24 44.22 38.80 37.99 30.31 38.84 18.97 11.80 5.87 3.20

Top Investors:

orbimed asia iv mauritius fvci limited

uti-healthcare fund

kotak mahindra trustee co ltd a/c kotak special opportunities fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Marksans Pharma - Quarterly Results
13th Aug 2026, 00:00 AM

Read More
Marksans Pharma reports near three-fold jump in Q1 consolidated net profit
12th Aug 2026, 14:28 PM

The total consolidated income of the company has increased by 38.45% at Rs 866.20 crore for Q1FY27
Read More
Marksans Pharma inks pact to acquire 100% stake in ABCnow GmbH
8th Jul 2026, 11:19 AM

The acquisition is expected to be completed by July 31, 2026
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback